Virulence Inactivating Protein™ (VIP™)
Novel biological solutions for reducing the risk of gastrointestinal infections in animals and humans
HIGH PRECISION
Bactolife™’s solutions (VIPs™) are designed to reduce virulence of gastrointestinal pathogens, minimizing unwanted interactions with host and low propensity for resistance development.
EARLY ACTION
Bactolife™’s solutions (VIPs™) are based on establishing a healthy microbiome able to avoid the disease onset through reduction of virulence, making pathogens unable to dominate the gut.
COST- EFFECTIVE
Due to the unique design of Bactolife™’s technology, our VIPs™ are stable, highly cost-effective, and can be produced in large-scale using state-of-the-art systems for biomanufacturing.
EASY TO USE
Bactolife™’s VIP™s are orally administered, stable, and easy to use.
Virulence factors, colonization tools
Pathogens express a wide variety of virulence factors, which allow them to overcome colonization resistance and survive in the harsh environment present in the gut.
A major cause of mortality
Colonization and immune evasion
Diverse molecular nature
Key to unlock inflammation
Non-essential for survival
Competition with commensals
The holobiont, explained
The holobiont is the entity comprised of the host and all of its symbiotic microbes. These microbes may be transmitted vertically or horizontally, may be acquired from the environment, and can change.
Improving collaboration between humans, animals, and the microbiome
Awareness of the impact of the microbiome on human health has increased in recent years and there is a need for re-evaluating what makes up a person and the way we treat and handle infections. In Bactolife™, we work towards equilibrium rather than eradication of components of the holobiont.
